M3 Inc
TSE:2413
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Jinli Group Holdings Ltd
TWSE:8429
|
KY |
M3 Inc
EPS (Diluted)
M3 Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M3 Inc
TSE:2413
|
EPS (Diluted)
¥73
|
CAGR 3-Years
2%
|
CAGR 5-Years
9%
|
CAGR 10-Years
15%
|
|
|
S
|
Software Service Inc
TSE:3733
|
EPS (Diluted)
¥1.1k
|
CAGR 3-Years
17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
|
|
Medley Inc
TSE:4480
|
EPS (Diluted)
¥30
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
CareNet Inc
TSE:2150
|
EPS (Diluted)
¥37
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
Medical Data Vision Co Ltd
TSE:3902
|
EPS (Diluted)
¥7
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
6%
|
|
|
JMDC Inc
TSE:4483
|
EPS (Diluted)
¥125
|
CAGR 3-Years
31%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
M3 Inc
Glance View
M3 Inc. emerged from Japan in the late 1990s, rapidly morphing from a novel digital venture into a formidable player in the global medical information services arena. The company's genesis was rooted in the transformative vision of leveraging web-based platforms to bridge vast distances between healthcare professionals, providing them with timely, accurate information and resources. As the internet began revolutionizing industries, M3 Inc. seized this opportunity, focusing on creating a seamless digital environment that connected pharmaceutical companies with medical professionals. Their flagship offering, M3.com, became a pivotal platform—essentially serving as a nexus where healthcare giants could introduce their latest products and innovations to an audience of medical practitioners, facilitating informed decision-making and nurturing vital industry relationships. Reaching beyond Japanese shores, M3 Inc. strategically expanded its influence into markets in Europe, the United States, and further afield, deftly tailoring its platforms to meet diverse regulatory standards and cultural nuances. Today, its financial vitality is driven by a multifaceted business model. Primarily, M3 derives revenue from pharmaceutical companies and medical device makers who pay for advertising space and market research insights on its network, valuing the direct engagement with physicians it facilitates. Moreover, the company has smartly diversified its portfolio by incorporating online healthcare services and physician recruitment, offering a comprehensive suite of services that cater to the evolving needs of the medical community. By aligning its growth with the digital evolution of the healthcare industry, M3 Inc. continues to solidify its role as a linchpin in the health information ecosystem.
See Also
What is M3 Inc's EPS (Diluted)?
EPS (Diluted)
73.2
JPY
Based on the financial report for Dec 31, 2025, M3 Inc's EPS (Diluted) amounts to 73.2 JPY.
What is M3 Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
15%
Over the last year, the EPS (Diluted) growth was 21%. The average annual EPS (Diluted) growth rates for M3 Inc have been 2% over the past three years , 9% over the past five years , and 15% over the past ten years .